论文信息 - Patient-Reported Outcomes with Selpercatinib Treatment Among Patients with RET-Mutant Medullary Thyroid Cancer in the Phase 1/2 LIBRETTO-001Trial. - 字舞流文

Patient-Reported Outcomes with Selpercatinib Treatment Among Patients with RET-Mutant Medullary Thyroid Cancer in the Phase 1/2 LIBRETTO-001Trial.

L. Wirth | V. Subbiah | V. Boni | E. Massarelli | M. Jen | C. McCoach | L. Hess | J. Kherani | E. Olek | B. Robinson | Daniel Tan | D. Tan